Medical Insurance Market to Gain Impetus from Strategic Collaborations among Leading Enterprises



Description
The goal of this report is to characterize, portray, and estimate the market on the premise of sort, application, therapeutic condition, and area. It gives point-by-point data with respect to the main considerations influencing the development of the market. This report likewise tracks and examines aggressive improvements of the key players regarding market advancements, item portfolios, and financials


Gross written premiums in the private medical insurance category amounted to GBP3.65 billion in 2012, recording growth of 3.2% from 2011, and a compound annual growth rate (CAGR) of 2.47% during the review period (2008-2012)

Favorable developments in premiums belie the underlying trends in demand, however. As a discretionary insurance product, supplementary to free-to-access healthcare through the National Health Service (NHS), the number of private medical policyholders has been subject to a downwards trend since 2006 and hit its lowest level on record in 2012, at 5.6 million. Factors driving the apparent shift in attitudes include improved levels of satisfaction with the NHS, increased public healthcare spending, and deterioration in labor market conditions.

The market for private medical insurance is dominated by four insurers - Bupa, Axa, Aviva and Prudential - which have a combined market share of 92%. Despite this concentrated market, a lack of competition between private hospital operators has restricted insurers' bargaining power and resulted in inflated claims costs. Coupled with the decline in customer numbers, this has been the biggest driver of premium growth as insurers responded to drags on profitability by raising prices for customers.

The consumer shift away from private medical insurance is unlikely to be fully reversed. Nevertheless, favorable forces will underpin a modest CAGR of 2% for gross written premiums over the forecast period (2013-2017). A recovery in economic growth will improve wage and employment conditions, NHS reforms are expected to advance the role of the private healthcare and insurance sector, while the UK's evolving demographic profile will increase the strain on the public healthcare system.
Improving economic conditions do not prescribe continued growth in the category, however, as the recession-induced demand for lower-cost policy coverage has spurred an increase in the popularity and availability of cheaper healthcare cash plans and self-pay options for one-off treatments. This new market dynamic threatens to divert customers away from comprehensive, but high-premium private medical insurance policies.  

Scope

This report provides market analysis, information and insights into the UK private medical insurance business
It provides a global snapshot of market size
It analyses drivers and the outlook for the market
It provides information on distribution channels
It covers deals, news and regulatory developments 

Reason To Buy
 Gain an understanding of the UK private medical insurance market size
Learn about the performance of market drivers and distribution channels
Understand the competitive landscape in terms of performance, profitability and product innovation
Find out more on key deals and recent developments in the market
 
Key Highlights
 Private medical insurance premiums rose by 3.2% in 2012
Demand shifted away from the private healthcare sector
Minimal competition among private suppliers has increased costs for insurers
Competition Commission intervention should begin to alleviate cost constraints
Premium growth will be sustained, despite opposing forces
Private medical insurance is under threat from lower-cost alternatives


This report is a total investigation of ebb and flow inclines in the market, business development drivers, and restrictions. It gives showcase projections to the coming years. It incorporates investigation of late advancements in innovation, Doorman's five power demonstrate examination and point by point profiles of best industry players. The report additionally incorporates a survey of miniaturized scale and large-scale factors fundamental for the current market players and new participants alongside nitty gritty esteem chain examination

About Us

Radiant Insights is a market research and consulting company offering syndicated research studies, customized reports, and consulting services. Our market research studies are designed to facilitate strategic decision making, on the basis of extensive and in-depth quantitative information, supported by extensive analysis and industry insights. Using a patented and robust research methodology, we publish exhaustive research reports covering a host of industries such as Technology, Chemicals, Materials, and Energy. Radiant Insights has a strong base of analysts, consultants and domain experts, with global experience helping us deliver excellence in all research projects we undertake

Contact Us

Michelle Thoras
Corporate Sales Specialist, USA
Radiant Insights, Inc
201 Spear Street 1100, Suite 3036, San Francisco, CA 94105, United States
Tel: 1-415-349-0054
Toll Free: 1-888-928-9744

No comments:

Post a Comment

Screen Capture Software Market Effective Strategies to Facilitate Growth

Description The goal of this report is to characterize, portray, and estimate the market on the premise of sort, application, t...